Pleural and Lung Cancer
10+ Years of Experience
Board Certified in Medical Oncology
Board Certified in Hematology
Gettinger joined the staff as a board-certified medical oncologist at the Smilow Cancer Hospital, a National Cancer Institute (NCI)-designated comprehensive cancer center. Working within the thoracic oncology program, Gettinger treats a variety of cancers that originate in the thoracic cavity, such as chest wall tumors, lung cancer, mediastinal tumors, thymomas and malignant mesothelioma.
His role at the cancer center is to work “closely with the Head and Neck Cancer Program to develop multidisciplinary approaches to treat patients with locally advanced disease and to develop innovative treatment regimens incorporating novel targeted agents.”
We can help you or a loved one get in contact with Dr. Gettinger and find the treatment that's best for you.Get Started Today
Heavily involved with internal medicine, Gettinger has contributed to a number of clinical trials exploring lung cancer and other thoracic malignancies. His clinical trials have explored the effects of the prominent chemotherapy drugs pemetrexed, Docetaxel and carboplatin, among other types of treatment.
Gettinger’s other research has included clinical trial design; novel therapeutics for the treatment of lung and other thoracic cancers; and biomarkers, which are specific proteins found in a patient’s blood that may indicate the presence or absence of a certain illness.
Dr. Gettinger accepts appointments directly from patients wishing to see him as well as those referred by their physician.
Gettinger’s medical practice was launched in 1999 when he graduated from medical school at the State University of New York at Brooklyn College. He later completed a consecutive residency and fellowship at the Beth-Israel Medical Center in New York City. He has served at Yale University since 2005 and is also an assistant professor of Medicine and Medical Oncology.
Gettinger’s 14 publications deal with targeted therapy, non-small cell lung cancer and novel forms of chemotherapy. His articles have appeared in the Journal of Clinical Oncology and Clinical Cancer Research, among other scientific publications.
Disclaimer: Dr. Scott N. Gettinger has no professional affiliation with Asbestos.com.
Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers. Read More